Since the anthrax attacks in 2001, anthrax has remained a major focus of national emergency-preparedness planning. Bacillus anthracis, the bacterium that causes anthrax, is concerning because it can rapidly progress to systemic disease with high mortality if untreated.
If an intentional release of anthrax were to occur, children would require special consideration because the clinical presentation and progression of disease in children may differ from that in adults. Children could be at higher risk of developing systemic disease and/or meningoencephalitis, the symptoms they experience may mimic those of other illnesses, and little is known about the signs and symptoms of anthrax in infants younger than 2 months of age.
To address these issues, the American Academy of Pediatrics and the Centers for Disease Control and Prevention released a report[1] focusing specifically on the clinical needs of children during an anthrax emergency. The report provides the most current guidance on caring for children after an intentional release of B anthracis and includes information on the diagnosis and management of anthrax in pediatric populations, antimicrobial and vaccine use, and treatment options.
Since the anthrax attacks in 2001, anthrax has remained a major focus of national emergency-preparedness planning. Bacillus anthracis, the bacterium that causes anthrax, is concerning because it can rapidly progress to systemic disease with high mortality if untreated.
If an intentional release of anthrax were to occur, children would require special consideration because the clinical presentation and progression of disease in children may differ from that in adults. Children could be at higher risk of developing systemic disease and/or meningoencephalitis, the symptoms they experience may mimic those of other illnesses, and little is known about the signs and symptoms of anthrax in infants younger than 2 months of age.
To address these issues, the American Academy of Pediatrics and the Centers for Disease Control and Prevention released a report[1] focusing specifically on the clinical needs of children during an anthrax emergency. The report provides the most current guidance on caring for children after an intentional release of B anthracis and includes information on the diagnosis and management of anthrax in pediatric populations, antimicrobial and vaccine use, and treatment options.
การแปล กรุณารอสักครู่..